Skip to content

Study of fiber-enriched botanicals in constipation mitigation among middle-aged and elderly people

Effects of two aperient products on constipation mitigation in middle-aged and elderly people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070441
Enrollment
Unknown
Registered
2023-04-12
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation

Interventions

control group:Take maltodextrin
intervention group A:Take Qingchang capsule
intervention group B:Take aperient powder

Sponsors

School of Public Health, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45-65 years; 2. Meet the Rome IV diagnostic criteria for functional constipation (also known as habitual constipation), spontaneous defecation less than 3 times per week; 3. Voluntary and able to comply with test requirements, timely return visit and signed informed consent and confidentiality agreement.

Exclusion criteria

Exclusion criteria: 1. Those who cannot eat by mouth or take the test sample as prescribed; 2. Those who have unclear chief complaint or are too weak to conduct the experiment; 3. Patients with constipation symptoms caused by surgical operations within 30 days or with a history of colon/anal operations; 4. Recent defecation difficulties caused by organoplasmic diseases (colon cancer, severe enteritis, intestinal obstruction, inflammatory bowel disease, etc.); 5. Difficulty in defecation accompanied by pain; 6. Patients with acute gastrointestinal disease within 30 days; 7. Pregnant and menstruating patients; 8. Patients with serious systemic diseases such as cardiovascular, liver, kidney and hematopoietic system; 9. Those who are being treated for other concomitant diseases; 10. Recent use of medicinal foods that may affect constipation symptoms and/or intestinal flora composition, such as antibiotics, laxatives or diuretics, prebiotics, probiotics, etc.; 11. Other conditions for which participation in the trial is not considered appropriate by the doctor.

Design outcomes

Primary

MeasureTime frame
frequency of defecation;

Secondary

MeasureTime frame
status of defecation;Bristol Stool Scale;quality of life;gut microbiota;body mass index;blood pressure;other anthropometric measurements;dietary intake;

Countries

China

Contacts

Public ContactYing Chenjiang

School of Public Health, Tongji Medical College, Huazhong University of Science and Technology

yingcj@hust.edu.cn+86 15907191282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026